EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Indole-3-carbinol attenuates DNCB-induced atopic dermatitis in mice by reducing inflammation and IL-4/IL-13 expression

Rabbia Kalim, Arham Shabbir, Hafsa Nasr, Aisha Mobashar, Abdulelah Alhazza, Hamoud Alotaibi, Mona Al Hamod, Saleh Alfuraih, Ali F Almutairy, Sulaiman M Alnasser, Waad Alrohily, Ashfaq Ahmad

Biomolecules and Biomedicine · 2026

DOI: 10.17305/bb.2026.14424 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules and Biomedicine, 2026. Verfasst von Rabbia Kalim und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Institute of Pharmacy, Faculty of Pharmaceutical and Allied Health Sciences, Lahore College for Women University, Lahore,…. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Interleukin-13, Interleukin-4, Indoles. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis (AD), commonly known as atopic eczema, is a chronic inflammatory skin disease. Indole-3-carbinol (I3C), a phytochemical naturally occurring in Brassica vegetables, has been traditionally used in folk medicine for inflammatory and metabolic disorders. This study investigated the immunomodulatory and anti-inflammatory effects of I3C in a mouse model of 1-chloro-2,4-dinitrobenzene (DNCB)-induced atopic dermatitis. Atopic dermatitis was induced by DNCB sensitization on days 0 and 3. Following disease confirmation on day 7, mice received daily oral or topical administrations of I3C or prednisolone from day 7 to day 19. Macroscopic evaluations included dorsal skin and ear thickness measurements. Histopathological changes were assessed using hematoxylin and eosin staining, and hematological parameters were also analyzed. Gene expression of interleukin (IL)-4 and IL-13 in ear tissue was quantified by real-time polymerase chain reaction (RT-qPCR). Computational molecular docking was performed to determine I3C's affinity for both cytokines. The data indicated that I3C attenuated DNCB-induced AD-like symptoms following both oral and topical administration. Treatment with I3C also resulted in reduced ear thickness. Hematological analysis revealed significantly decreased total leukocyte counts (TLC) and a general downward numerical trend in differential leukocyte count (DLC) parameters in I3C-treated groups. Histopathological evaluation confirmed that I3C ameliorated skin thickening and reduced inflammatory cell infiltration. Furthermore, IL-4 and IL-13 expression levels were decreased in I3C-treated groups. Molecular docking analysis demonstrated moderate binding affinities of -5.1 kcal/mol and -5.3 kcal/mol with IL-4 and IL-13, respectively. In conclusion, findings from this exploratory study suggest that I3C treatment ameliorated DNCB-induced atopic dermatitis in mice, evidenced by reductions in ear thickness and IL-4/IL-13 mRNA expression. Molecular docking analysis demonstrated moderate binding affinities of I3C toward IL-4 and IL-13, providing supportive evidence of potential ligand-protein interactions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicInterleukin-13Interleukin-4IndolesInflammationAnimalsMiceDinitrochlorobenzeneMolecular Docking SimulationFemaleMice, Inbred BALB CDisease Models, AnimalMaleAnti-Inflammatory AgentsGene Expression Regulation

Substanzen

indole-3-carbinolInterleukin-13Interleukin-4DinitrochlorobenzeneIndolesIl4 protein, mouseAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Pharmacology, Institute of Pharmacy, Faculty of Pharmaceutical and Allied Health Sciences, Lahore College for Women University, Lahore, Pakistan.
  • Faculty of Pharmacy, The University of Lahore, Lahore, Pakistan.
  • Department of Pharmaceutics, Faculty of Pharmacy, Northern Border University, Rafha, Saudi Arabia.
  • Department of Pharmacology and Toxicology, College of Pharmacy, Northern Border University, Rafha, Saudi Arabia.
  • Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah, Saudi Arabia.
  • Department of Pharmacy Practice, College of Pharmacy, Taibah University, Medina, Saudi Arabia.

Zitieren

APA

Kalim, R., Shabbir, A., Nasr, H., Mobashar, A., Alhazza, A., Alotaibi, H., Al Hamod, M., Alfuraih, S., Almutairy, A. F., Alnasser, S. M., Alrohily, W., & Ahmad, A. (2026). Indole-3-carbinol attenuates DNCB-induced atopic dermatitis in mice by reducing inflammation and IL-4/IL-13 expression. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2026.14424

Vancouver

Kalim R, Shabbir A, Nasr H, Mobashar A, Alhazza A, Alotaibi H, et al. Indole-3-carbinol attenuates DNCB-induced atopic dermatitis in mice by reducing inflammation and IL-4/IL-13 expression. Biomolecules and Biomedicine. 2026. doi:10.17305/bb.2026.14424

BibTeX
@article{Kalim2026,
  author = {Kalim, Rabbia and Shabbir, Arham and Nasr, Hafsa and Mobashar, Aisha and Alhazza, Abdulelah and Alotaibi, Hamoud and Al Hamod, Mona and Alfuraih, Saleh and Almutairy, Ali F and Alnasser, Sulaiman M and Alrohily, Waad and Ahmad, Ashfaq},
  title = {Indole-3-carbinol attenuates DNCB-induced atopic dermatitis in mice by reducing inflammation and IL-4/IL-13 expression},
  journal = {Biomolecules and Biomedicine},
  year = {2026},
  doi = {10.17305/bb.2026.14424}
}
Kostenlos starten →